PROSPECTS FOR THE TREATMENT OF METASTATIC GASTRIC CANCER
Keywords:
gastric adenocarcinoma, anti-angiogenic chemotherapyAbstract
The surgical method is the main method of treatment for almost all types of malignant neoplasms of the stomach. For patients who cannot undergo radical resection or with metastatic disease, comprehensive treatment based on systemic antitumor therapy such as palliative surgery, radiation therapy, radiofrequency ablation (RF), intraperitoneal perfusion and arterial embolization is recommended, as they can help prolong survival and improve quality of life. Such cases should be discussed in an interdisciplinary commission for an optimal personalized treatment strategy
References
Ma, X., et al., Clinicopathological Characteristics and Prognoses of Elderly Gastric Cancer Patients after R0 Resection: A Multicenter Study in China. J Environ Pathol Toxicol Oncol, 2018. 37(1): p. 81-91.
Palaj, J., et al., The role of subtotal and total gastrectomy in the treatment of gastric cancer. Neoplasma, 2021. 68(3): p. 621-625.
Otsuka, R., et al., Subtotal versus total gastrectomy for remnant gastric cancer: a systematic review and meta-analysis of observational studies. Langenbecks Arch Surg, 2021. 406(5): p. 1379-1385.
Lee, S.H., et al., Risk Factors and Clinical Outcomes of Non-Curative Resection in Patients with Early Gastric Cancer Treated with Endoscopic Submucosal Dissection: A Retrospective Multicenter Study in Korea. Clin Endosc, 2020. 53(2): p. 196-205.
Banks, M., et al., British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut, 2019. 68(9): p. 1545-1575.
Japanese Gastric Cancer, A., Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer, 2017. 20(1): p. 1-19.
Sasako, M., et al., Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol, 2006. 7(8): p. 644-51.
Ajani, J.A., et al., Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2022. 20(2): p. 167-192.
Kota, I., et al., Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer. Eur J Surg Oncol, 2021. 47(2): p. 456-462.
Chittawadagi, B., et al., Laparoscopic D2 gastrectomy in advanced gastric cancer: Postoperative outcomes and long-term survival analysis. Asian J Endosc Surg, 2021. 14(4): p. 707-716.
Biondi, A., et al., Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol, 2015. 41(6): p. 779-86.
Ji, J., et al., Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: a randomized phase III trial (RESOLVE trial). Annals of Oncology, 2019. 30: p. v877.
Liang, Y.X., et al., [Significance of No.14v lymph node dissection for advanced gastric cancer undergoing D2 lymphadenectomy]. Zhonghua Wei Chang Wai Ke Za Zhi, 2013. 16(7): p. 632-6.
Eom, B.W., et al., Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery, 2014. 155(3): p. 408-16.
Shen, D.F., et al., Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma. World J Gastroenterol, 2008. 14(6): p. 936-8.
Eom, B.W., et al., Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer? Ann Surg Oncol, 2013. 20(8): p. 2669-75.
Eto, K., et al., Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications. Gastric Cancer, 2018. 21(4): p. 703-709.
Sasako, M., et al., D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med, 2008. 359(5): p. 453-62.
Kitano, S., et al., Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc, 1994. 4(2): p. 146-8.
Nagai, Y., et al., Laparoscope-assisted Billroth I gastrectomy. Surg Laparosc Endosc, 1995. 5(4): p. 281-7.
Asao, T., et al., Laparoscopically assisted total or distal gastrectomy with lymph node dissection for early gastric cancer. Br J Surg, 2001. 88(1): p. 128-32.
Ibanez Aguirre, F.J., et al., Laparoscopic gastrectomy for gastric adenocarcinoma. Long-term results. Rev Esp Enferm Dig, 2006. 98(7): p. 491-500.
Azagra, J.S., et al., Long-term results of laparoscopic extended surgery in advanced gastric cancer: a series of 101 patients. Hepatogastroenterology, 2006. 53(68): p. 304-8.
Ibanez, F.J., et al., [Laparoscopic surgery of gastric cancer]. An Sist Sanit Navar, 2005. 28 Suppl 3: p. 21-31.
Lee, W.J., et al., Totally laparoscopic radical BII gastrectomy for the treatment of gastric cancer: a comparison with open surgery. Surg Laparosc Endosc Percutan Tech, 2008. 18(4): p. 369-74.
Lerner, B.A., et al., Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. J Med Genet, 2022.
Pugliese, R., et al., Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures. Eur J Surg Oncol, 2009. 35(3): p. 281-8.
Parisi, A., et al., Current status of minimally invasive surgery for gastric cancer: A literature review to highlight studies limits. Int J Surg, 2015. 17: p. 34-40.
Katai, H., et al., Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol, 2020. 5(2): p. 142-151.
Kim, H.H., et al., Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol, 2019. 5(4): p. 506-513.
Hyung, W.J., et al., A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer, 2019. 22(1): p. 214-222.
Katai, H., et al., Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer, 2019. 22(5): p. 999-1008.
Liu, F., et al., Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial. JAMA Oncol, 2020. 6(10): p. 1590-1597.
Yu, J., et al., Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. JAMA, 2019. 321(20): p. 1983-1992.
Hyung, W.J., et al., Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial. J Clin Oncol, 2020. 38(28): p. 3304-3313.
Li, Z., et al., Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial. JAMA Surg, 2019. 154(12): p. 1093-1101.
Chen, Q.Y., et al., Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg, 2020. 155(4): p. 300-311.
Liu, F.L., et al., [Da Vinci robot-assisted gastrectomy with lymph node dissection for gastric cancer: a case series of 9 patients]. Zhonghua Wei Chang Wai Ke Za Zhi, 2010. 13(5): p. 327-9.
Hashizume, M. and K. Sugimachi, Robot-assisted gastric surgery. Surg Clin North Am, 2003. 83(6): p. 1429-44.
Shin, H.J., et al., Long-term Comparison of Robotic and Laparoscopic Gastrectomy for Gastric Cancer: A Propensity Score-weighted Analysis of 2084 Consecutive Patients. Ann Surg, 2021. 274(1): p. 128-137.
Lu, J., et al., Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial. Ann Surg, 2021. 273(5): p. 858-867.
Yanai, Y., et al., Endoscopic resection for gastrointestinal tumors (esophageal, gastric, colorectal tumors): Japanese standard and future prospects. Glob Health Med, 2021. 3(6): p. 365-370.
Ortega Lobete, O., R. Diaz Ruiz, and L. Perez Carazo, Primary gastric adenocarcinoma in a patient with Peutz-Jeghers syndrome. Rev Esp Enferm Dig, 2021. 113(6): p. 474-475.
Hasuike, N., et al., A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607). Gastric Cancer, 2018. 21(1): p. 114-123.
Japanese Gastric Cancer, A., Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer, 2021. 24(1): p. 1-21.
Esaki, M., E. Ihara, and T. Gotoda, Endoscopic instruments and techniques in endoscopic submucosal dissection for early gastric cancer. Expert Rev Gastroenterol Hepatol, 2021. 15(9): p. 1009-1020.
Thiruvengadam, S.S., et al., Endoscopic Mucosal Resection: Best Practices for Gastrointestinal Endoscopists. Gastroenterol Hepatol (N Y), 2022. 18(3): p. 133-144.
Repici, A., et al., Endoscopic submucosal dissection of early gastric neoplastic lesions: a western series. Eur J Gastroenterol Hepatol, 2013. 25(11): p. 1261-4.
Abe, S., et al., Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy, 2013. 45(9): p. 703-7.
Chaves, D.M., et al., Initial experience of endoscopic submucosal dissection in Brazil to treat early gastric and esophagheal cancer: a multi-institutional analysis. Arq Gastroenterol, 2013. 50(2): p. 148-52.
Farhat, S., et al., Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy, 2011. 43(8): p. 664-70.
Feng, Y., et al., Associated risk factor analysis and the prognostic impact of positive resection margins after endoscopic resection in early esophageal squamous cell carcinoma. Exp Ther Med, 2022. 24(1): p. 457
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
